Following up on our recent endocannabinoid system (ECS)-related posts, in many conditions, diseases which respond to medical cannabis are related to inadequate levels of the body’s own internally produced cannabinoids.
Production can be inhibited due to many possible causes, from genetic factors to stress, to other diseases, pain, chemical exposures, general nutrition, overall health habits, age, etc.
In using whole plant medical cannabis, then, it is the body’s intake of the plant’s phytocannabinoids (like CBD and THC and 80+ more) which helps restore the body’s ECS to more normal levels and more optimal functioning.
Some scientists thus believe that it makes as much sense to describe cannabis as a “restorative neutraceutical” as much as a “drug.”
Drugs can be beneficial or destructive but nearly all are things not normally found in the human body, whereas cannabis brings compounds to the ECS which are virtually bio-identical to human endocannabinoids.
“While studies concerning both ECS and ECD are in their infancy, ECD manifestation in migraine headaches has received some attention in the medical field—which is also in relation to medical cannabis.
In fact, in one relevant study doctors studied the cerebrospinal fluids from a group of 15 migraine victims and found that they all had low levels of ‘anandamide.’ This novel medical term denotes a compound manufactured within the human body that resembles marijuana plant sourced cannabinoids on a cellular level.”
Note: “Anandamide” is a neurotransmitter (and an endocannabinoid) produced in the brain that binds to the THC receptors.
Anandamide is often called the “bliss molecule.” It was coined by the researchers who discovered it from ‘ananda,’ which is the ancient Sanskrit word for ‘joy, bliss, or happiness.’ It is considered an endocannabinoid.
Namaste from TRUCE… ?
#MMJ #Research #ECD #Migraine #UTpol #UtahNext #TRUCE
See full article – The Facts On Endocannabinoid Deficiency And Medical Marijuana